mylife Diabetes Care Denmark ApS
Private limited companyCVR 39888041København KActive
mylife Diabetes Care Denmark ApS is a private limited company, based in København K, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2018. Net profit rose 97% from 2025 to 2026, ending at DKK 850k. Profit has grown three years in a row. Equity grew to DKK 5.8m in 2026.
Key figures · financial year 2026
What has changed
calculated from recorded figures and datesFinancials: 2026 against 2025
- Gross profit rose 83% (2025 → 2026), to DKK 9.5m.
- Net profit rose 97% (2025 → 2026), to DKK 850k.
- Equity rose 17% (2025 → 2026), to DKK 5.8m.
Management and owners, last 24 months
- New in management: Agnès Claire Francoise Simon (chair of the board, 16/01/2025), Beat Keller (deputy chair, 16/01/2025) and Johan Conny Lundström (board member, 16/01/2025).
- Stepped down: Niklaus Ramseier (board member, 16/01/2025), Simon Michel (board member, 16/01/2025) and Dirk Scherff (board member, 16/01/2025).
- New owners registered: mylife Diabetes Care AG (09/12/2024).
- No longer registered as owner: Ypsomed AG (09/12/2024).
Registrations, last 24 months
- 01/04/2026: Name changed from Ypsomed ApS to mylife Diabetes Care Denmark ApS
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2021–2026 · amounts in DKK thousandEquity and net profit
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 2,547 | 2,665 | 2,838 | 4,195 | 5,181 | 9,501 | +83.4% |
| Operating profit (EBIT) | 149 | 152 | 255 | – | – | 1,116 | – |
| Profit before tax | 120 | 136 | 258 | 455 | 560 | 1,099 | +96.2% |
| Net profit | 92 | 105 | 199 | 323 | 432 | 850 | +96.9% |
| Total assets | 5,500 | 5,134 | 6,991 | 7,606 | 8,871 | 15,710 | +77.1% |
| Equity | 3,893 | 3,999 | 4,198 | 4,521 | 4,953 | 5,803 | +17.2% |
| Liabilities | 1,607 | 1,136 | 2,793 | 3,085 | 3,918 | 9,908 | +152.9% |
| Cash and cash equivalents | 837 | 396 | 2,422 | 1,372 | 2,099 | 3,420 | +63% |
| Average number of employees | 7 | 3 | 3 | 5 | 5 | 5 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025, 2026: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2026 figuresProfit for five years in a row
Net result has been positive in 2022–2026.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2026 | 01/04/2025 – 31/03/2026 | 30/09/2026 | The company | PDF not statedXBRL |
| 2025 | 01/04/2024 – 31/03/2025 | 30/09/2025 | The company | PDF not statedXBRL |
| 2024 | 01/04/2023 – 31/03/2024 | 04/10/2024 | The company | PDFXBRL |
| 2023 | 01/04/2022 – 31/03/2023 | 03/07/2023 | The company | PDFXBRL |
| 2022 | 01/04/2021 – 31/03/2022 | 04/07/2022 | The company | PDFXBRL |
| 2021 | 01/04/2020 – 31/03/2021 | 16/07/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 5,247of 69,742 Better than 92% | No. 12,851of 69,964 Better than 82% |
| Same industry and fewer than 20 employees150 companies in the comparison | No. 46of 150 Better than 70% | No. 57of 150 Better than 62% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 4,639of 33,588 Better than 86% | No. 5,472of 33,687 Better than 84% |
| All companies of type ApS66,508 companies in the comparison | No. 6,520of 66,379 Better than 90% | No. 10,113of 66,505 Better than 85% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- mylife Diabetes Care Denmark ApSDKK 9.5m
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- mylife Diabetes Care Denmark ApSDKK 850k
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- mylife Diabetes Care Denmark ApSDKK 5.8m
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- mylife Diabetes Care Denmark ApS6
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- mylife Diabetes Care AG100%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Anja Pihl Bovien | Director | 24/09/2018 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Agnès Claire Francoise Simon | Chair of the board | 16/01/2025 |
| Beat Keller | Deputy chair | 16/01/2025 |
| Johan Conny Lundström | Board member | 16/01/2025 |
- Founders
- Ypsomed Aktiebolag
Former management (4)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Niklaus Ramseier | Board member | 24/09/2018 | 16/01/2025 |
| Simon Michel | Board member | 24/09/2018 | 16/01/2025 |
| Eberhard Bauer | Board member | 24/09/2018 | 22/02/2022 |
| Dirk Scherff | Board member | 22/02/2022 | 16/01/2025 |
Signing rule: Selskabet tegnes af 1 direktør eller af den samlede bestyrelse.
Address and production units
1 active production unitsHammerensgade 1
1267 København K
København Municipality · Postcode 1267
Other companies at the address (8)
- BenBau ApSConstruction of buildings
- Citycallcenter ApSActivities of call centres
- Euro Site Services DK ApSTemporary employment agency activities and other staff provision
- DL ApSCombined facilities support activities
- Proselection ApSTemporary employment agency activities and other staff provision
| Production unit | Address | Employees | P number |
|---|---|---|---|
| mylife Diabetes Care Denmark ApS | Hammerensgade 1, 2, 1267 København K | 6 | 1023983865 |
Purpose
Selskabets formål er at drive virksomhed med salg af diabeteshjælpemidler til danske forbrugere samt anden virksomhed, der står i forbindelse hermed.
The purpose is quoted from the register in Danish.
Changes year by year
28 registered events20262 changesaccounts 1 · name 1
- AccountsAnnual report for 2026 published
- NameName changed from Ypsomed ApS to mylife Diabetes Care Denmark ApS
20257 changesaccounts 1 · management 6
- AccountsAnnual report for 2025 published
- ManagementAgnès Claire Francoise Simon appointed chair of the board
- ManagementBeat Keller appointed deputy chair
- ManagementJohan Conny Lundström appointed board member
- ManagementDirk Scherff stepped down as board member
- ManagementSimon Michel stepped down as board member
- ManagementNiklaus Ramseier stepped down as board member
20243 changesownership 2 · accounts 1
- Ownershipmylife Diabetes Care AG registered as owner (100%)
- OwnershipYpsomed AG is no longer registered as owner
- AccountsAnnual report for 2024 published
20232 changesaddress 1 · accounts 1
- AddressMoved to Hammerensgade 1, 2, 1267 København K
- AccountsAnnual report for 2023 published
20224 changesaddress 1 · accounts 1 · management 2
- AddressMoved to Hammerensgade 1, 2, 1267 København K
- AccountsAnnual report for 2022 published
- ManagementDirk Scherff appointed board member
- ManagementEberhard Bauer stepped down as board member
20212 changesaddress 1 · accounts 1
- AddressMoved to Marielundvej 20, 2730 Herlev
- AccountsAnnual report for 2021 published
20188 changesownership 3 · founded 1 · management 4
- OwnershipYpsomed AG registered as owner (100%)
- OwnershipYpsomed Aktiebolag is no longer registered as owner
- FoundedRegistered as Ypsomed ApS
- ManagementAnja Pihl Bovien appointed director
- ManagementSimon Michel appointed board member
- ManagementEberhard Bauer appointed board member
- ManagementNiklaus Ramseier appointed board member
- OwnershipYpsomed Aktiebolag registered as owner (100%)
Related companies
Same industry in København
- Nomeco A/S939 employees
- Abacus Medicine A/S388 employees
- Novo Nordisk Denmark A/S300 employees
- Msd Danmark ApS132 employees
- Astrazeneca A/S122 employees
- Sandoz A/S118 employees
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.